A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation

Nephrology Dialysis Transplantation

Volumn 21, Issue 10, 2006, Pages 2825-2833

  Sosa, Marie Anne ^a,b   Balk, Ethan M ^c   Lau, Joseph ^c   Liangos, Orfeas ^a,b,d   Balakrishnan, Vaidyanathapuram S ^d   Madias, Nicolaos E ^a,b,d   Pereira, Brian J G ^d   Jaber, Bertrand L ^a,b,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c Institute for Clinical Research and Health Policy Studies   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Excebrane; Haemodialysis; Lipid peroxidation; Meta analysis; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

CLINICAL TRIAL; COCHRANE LIBRARY; DIALYSIS MEMBRANE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFORMATION RETRIEVAL; KIDNEY FAILURE; LIPID ANALYSIS; LIPID PEROXIDATION; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; STATISTICAL MODEL; SYSTEMATIC REVIEW;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CONTROLLED CLINICAL TRIALS; CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; PUBMED; RENAL DIALYSIS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 33749593521     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl376     Document Type: Review

References (61)

1. Giardini O, Taccone-Gallucci M, Lubrano R et al. Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron 1984; 36: 235-237
2. Taccone-Gallucci M, Giardini O, Lubrano R et al. Pentosephosphate shunt activity and red blood cell malonyldialdehyde levels in haemodialysis and in CAPD patients. Life Support Syst 1985; 3 [Suppl 1]: 121-124
3. Himmelfarb J, Stenvinkel P, Ikizler T, Hakim R. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538
4. Locatelli F, Canaud B, Eckardt K, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-1280
5. Garry H. Current studies on oxidative stress in dialysis. Blood Purif 2003; 21: 46-50
6. Jaber BL, Pereira BJ. Biocompatibility of hemodialysis membranes. In: Pereira B, Sayegh M, Blake P, eds. Chronic Kidney Disease, Dialysis and Transplantation: A Companion to Brenner and Rector's The Kidney, 2nd edn Philadelphia, PA, Elsevier Saunders: 2005; 363-387
7. Roob J, Khoschsorur G, Tiran A, Horina J, Holzer H, Winklhofer-Roob B. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000; 11: 539-549
8. (K/DOQI) KDOQI: Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 2005; 45 [Suppl 3]: 16-153
9. Himmelfarb J, Lazarus J, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991; 17: 271-276
10. Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM. Intradialytic granulocyte reactive oxygen species production: A prospective, crossover trial. J Am Soc Nephrol 1993; 42: 178-186
11. Ward R, McLeish K. Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs 1905; 19: 801-807
12. Galli F, Rovidati S, Chiarantini L, Campus G, Canestrari F, Buoncristiani U. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int 1998; 54: 580-589
13. Pertosa G, Grandaliano G, Valente M et al. In vivo evaluation of biocompatibility of a new dialyzer employing the vitamin E-modified cellulose membrane 'Excebrane E': Study of mechanisms involved in mononuclear cell activation. Contrib Nephrol 1999; 127: 200-207
14. MacGinley R, Westhuyzen J, Saltissi D, Morgan C, Healy H, Thirlwell GK, Disney AP. Evaluation of a novel vitamin E coated cellulosic membrane hollow fiber dialyzer. ASAIO J 2001; 47: 66-73
15. Galli F. Vitamin E-modified dialysers. Contrib Nephrol 2002; 37: 95-105
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
17. Balk E, Lau J, Goudas L et al. Effects of statins on nonlipid serum markers associated with cardiovascular disease: A systematic review. Ann Intern Med 2003; 139: 670-682
18. Hedges L, Olkin I. Statistical Methods for Meta-Analysis, Academic Press, San Diego, CA: 1985; 78
19. Whitehead A. Meta-Analysis of Controlled Clinical Trials, West Essex, England, John Wiley & Sons, Ltd: 2002
20. Gardner CD, Kraemer HC. Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis. Arterioscler Thromb Vase Biol 1995; 15: 1917-1927
21. Gotzsche PC, Johansen HK. Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Br Med J 1998; 316: 811-818
22. Huang G, Shi X, Davis-Brezette J, Osness W. Resting heart rate changes after endurance training in older adults: A meta-analysis. Medicine & Science in Sports & Exercise 2005; 37: 1381-1386
23. Buoncristiani U, Galli F, Rovidati S, Albertini MC, Campus G, Canestrari F. Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: A preliminary characterization. Nephron 1997; 77: 57-61
24. Sommerburg O. Oxidative stress in hemodialysis patients treated with a dialysis membrane which has alpha-tocopherol bonded to its surface. Bio Factors 1999; 10: 121-124
25. Mune M, Yukawa S, Kishino M et al. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int 1999; 71 [Suppl]: S126-S129
26. Bonnefont-Rousselot D, Lehmann E, Jaudon MC, Delattre J, Perrone B, Rechke JP. Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: Effect of the use of a vitamin E-coated dialysis membrane. Nephrol Dial Transplant 2000; 15: 2020-2028
27. Galli F, Varga Z, Balla J et al. Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int 2001; 78 [Suppl] 78: S148-S154
28. Eiselt J. Effects of a vitamin E-modified dialysis membrane and vitamin C infusion on oxidative stress in hemodialysis patients. Artif Organs 2001; 25: 430-436
29. Mydlik M, Derzsiova K, Racz O, Sipulova A, Lovasova E, Petrovicova J. A modified dialyzer with vitamin E and antioxidant defense parameters. Kidney Int 2001; 78 [Suppl]: S144-S147
30. Shimazu T, Ominato M, Toyama K et al. Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production. Kidney Int 2001; 78 [Suppl]: S137-S143
31. Satoh M, Yamasaki Y, Nagake Y et al. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 2001; 59: 1943-1950
32. Tsuruoka S, Kawaguchi A, Nishiki K et al. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am J Kidney Dis 2002; 39: 127-133
33. Usberti M, Gerardi G, Bufano G et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis 2002; 40: 590-599
34. Triolo L. Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients. Artif Cell Blood Sub 2003; 31: 185-191
35. Hara T. Reduction of oxidized low-density lipoprotein by the long-term use of vitamin E-coated dialyzers in hemodialysis patients. Dialysis Transplant 2004; 33: 197-207
36. Mydlik M, Derzsiova K, Racz O et al. Vitamin E-coated dialyzer and antioxidant defense parameters: Three-month study. Semin Nephrol 2004; 24: 525-531
37. Bonnefout-Rousselot D, Jaudou MC, Issad B et al. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 1399-1405
38. Itabe H, Yamamoto H, Imanaka T et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 1996; 37: 45-53
39. Itabe H, Yamamoto H, Suzuki M et al. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein. J Biol Chem 1996; 271: 33209-33217
40. Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW. Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radic Biol Med 2001; 31: 1163-1169
41. Steinberg D. Beyond cholesterol. Modification of low density lipoprotein that increases its atherogenicity. N Engl J Med 1989; 320: 915-924
42. Boaz M, Smetana S, Weinstein T et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet 2000; 356: 1213-1218
43. Boaz M, Dotan Y, Iuliano L, Smetana S, Matas Z, Weinstein T. Vitamin E treatment benefit associated with baseline levels of oxidative stress in hemodialysis patients. J Am Soc Nephrol 2005; 16: 469A
44. Esterbauer H. Estimation of peroxidative damage. A critical review. Pathol Biol 1996; 44: 25-28
45. Lefevre G, Beljean-Leymarie M, Beyerle F et al. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Ann Biol Clin 1998; 56: 306-319.
46. Myers GL, Rifai N, Tracy RP et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report from the laboratory science discussion group. Circulation 2004; 110: E545-e549
47. Tatsioni A, Zarin DA, Aronson N et al. Challenges in systematic reviews of diagnostic technologies. Ann Intern Med 2005; 142: 1048-1055
48. Nakamura YK, Read MH, Elias JW, Omaye ST. Oxidation of serum low-density lipoprotein (LDL) and antioxidant status in young and elderly humans, Arch Gerontol Geriatr, 2005
49. Girndt M, Lengler S, Kaul H, Sester U, Sester M, Kohler H. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. Am J Kidney Dis 2000; 35: 95-104
50. Dhondt A, Vanholder R, Glorieux G et al. Vitamin E-bonded cellulose membrane and hemodialysis bioincompatibility: Absence of an acute. benefit on expression of leukocyte surface molecules. Am J Kidney Dis 2000; 36: 1140-1146
51. Morimoto H, Nakao K, Fukuoka K et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis, patients. Nephrol Dial Transplant 2005; 20: 2775-2782
52. Yagi K. Assay for blood plasma or serum. Methods Enzymol 1984; 105: 328-331
53. Oxis Research, Inc.: http://www.oxisresearch.com/products/assays/21012/ 21012.shtml (accessed on 3 May 2006).
54. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358
55. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212-216
56. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN, Jr, Sunderman FW. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987; 33: 214-220
57. Canestrari F, Galli F, Giorgini A et al. Erythrocyte redox state in uremic anemia: Effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol 1994; 91: 187-193
58. Canestrari F, Buoncristiani U, Galli F et al. Redox. state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients. Clin Chim Acta 1995; 234: 127-136
59. Jentzsch A. Improved analysis of malondialdehyde in human body fluids. Free Radical Bio Med 1996; 20: 251-256
60. Itabe H, Takeshima E, Iwasaki H et al. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem 1994; 269: 15274-15279
61. Itabe H. Anti-oxidized LDL monoclonal antibody recognizes foam cell. Atherosclerosis 1994; 22: 275-280